1. Home
  2. Live Updates
  3. Sara zelkovic

Live Breaking News & Updates on Sara zelkovic

Stay informed with the latest breaking news from Sara zelkovic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sara zelkovic and stay connected to the pulse of your community

Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase 1b Trial

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United-states , Mont-saint-guibert , Waals-gewest , Belgium , New-york , Walloon-region , Kenilworth , Sara-zelkovic , Filippo-petti , Merck-co-inc , Exchange-commission , Communications-investor-relations

Celyad Oncology Announces February 2022 Conference Schedule

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Sara-zelkovic , Filippo-petti , Exchange-commission , Communications-investor-relations , Lifesci-advisors , Global-healthcare-conference

Celyad Oncology SA: Celyad Oncology Announces February 2022 Conference Schedule

Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Paris , France-general- , France , Sara-zelkovic , Filippo-petti , Exchange-commission

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

31.12.2021 - MONT-SAINT-GUIBERT, Belgium, Dec. 31, 2021 (GLOBE NEWSWIRE) - Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for ...

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Sara-zelkovic , Filippo-petti , Exchange-commission , Communications-investor-relations , Lifesci-advisors , Chief-executive-officer

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) - Press Release

MONT-SAINT-GUIBERT, Belgium, Dec. 31, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA ((Euronext &amp, NASDAQ:CYAD), a clinical-stage biotechnology co

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Belgian , Sara-zelkovic , Filippo-petti , Exchange-commission , Communications-investor-relations , Lifesci-advisors

Celyad Oncology SA: Celyad Oncology Announces January 2022 Conference Schedule

Regulatory News: Celyad Oncology SA (Euronext Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Sara-zelkovic , Filippo-petti , Hc-wainwright-bioconnect , Exchange-commission , Communications-investor-relations , Lifesci-advisors

Celyad Oncology Announces First Patient Dosed in KEYNOTE-B79 Phase 1b Trial

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Kenilworth , California , San-francisco , American , Sara-zelkovic , Charles-morris

Celyad Oncology SA: Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

Regulatory News: Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Paris , France-general- , France , Brussels , Bruxelles-capitale , Sara-zelkovic

Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group

MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News:Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (“Celyad” or the “Company”), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced th...

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , Paris , France-general- , France , American , Sara-zelkovic , Exchange-commission

Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Mont-saint-guibert , Waals-gewest , Belgium , New-york , United-states , Walloon-region , American , Sara-zelkovic , Exchange-commission , Communications-investor-relations , Lifesci-advisors , Meagher-flom